USNA  Usana Health Sciences Inc.




Consumer Durables


Specialty Chemicals

Market Cap.


Vuru Grade


Current Price

+0.47 (+0.44%)

Growth Price

Overvalued by 27.49%

Stability Price

Undervalued by 18.39%

Company Metrics

  • 20.00 P/E
  • 1.76 P/S
  • 6.65 P/B
  • 5.362 EPS
  • 54.96% Cash ROIC
  • 1.52 Cash Ratio
  • 0.00 / N/A % Dividend
  • 149,460.00 Avg. Vol.
  • 1.326B Market Cap.

Company Description

USANA Health Sciences, Inc. develops, manufactures, distributes, and sells nutritional and personal care products worldwide. It offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamin and mineral supplements that provide a foundation of nutrition for various age groups; optimizers that are targeted supplements suppor...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


USANA Health Sciences, Inc. (USNA) Under Fire In China
ValueWalk - Jul 15, 2014
Citron Research out with its latest report, this time on USANA Health Sciences, Inc. (NYSE:USNA). This week multiple media outlets in China have exposed the MLM schemes operated by USANA Health Sciences, Inc. (NYSE:USNA) in China - a must read ...
USANA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP ... - Business Wire (press release)
USANA Down 5% After Short Seller, Greenberg Separately Offer Negative News - Benzinga
Pivotal Research Starts USANA Health Sciences Inc. (USNA) at Buy (subscription) - Oct 20, 2014
Pivotal Research initiates coverage on USANA Health Sciences Inc. (NYSE: USNA) with a Buy rating and a price target of $100.00.
UPDATE: Pivotal Research Initiates Coverage On USANA Health Sciences
Benzinga - Oct 20, 2014
Pivotal Research Group initiated a Buy rating on USANA Health Sciences, Inc. (NYSE: USNA) with a $100 price target in a report issued Monday.
USANA Health Sciences Research Coverage Started at Pivotal Research (USNA) - Ticker Report
Earnings Reaction History: USANA Health Sciences Inc., 33.3% Follow-Through ...
Nasdaq - Oct 28, 2014
is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.
Stocks On the Move: Cliffs Natural Resources Inc, USANA Health Sciences, Inc ...
Schaeffers Research (blog) - Oct 29, 2014
Among specific names making notable moves, though, are mining magnate Cliffs Natural Resources Inc (NYSE:CLF), nutritional supplement specialist USANA Health Sciences, Inc. (NYSE:USNA), and cloud component concern Aerohive Networks Inc ...
Midday Gainers From October 29: USANA Health, Corporate Executive Board ... - Benzinga
USANA Health Sciences, Inc. (USNA) Releases FY14 Earnings Guidance - WKRB News
USANA Health Sciences, Inc. (USNA) Misses Q2 EPS by 14c (subscription) - Jul 29, 2014
USANA Health Sciences, Inc. (NYSE: USNA) reported Q2 EPS of $1.36, $0.14 worse than the analyst estimate of $1.50. Revenue for the quarter came in at $188.3 million versus the consensus estimate of $198.3 million.
Investor Alert: USANA Health Sciences, Inc. (NYSE:USNA) under Investigation - GroundReport
New Vitamin D Research: Supplementation Is Best Way To Improve Vitamin D ... - PR Newswire (press release)
Harwood Feffer LLP Announces Investigation of USANA Health Sciences, Inc.
MarketWatch - Jul 17, 2014
NEW YORK, July 16, 2014 /PRNewswire/ -- Harwood Feffer LLP ( is investigating potential claims against USANA Health Sciences, Inc. ("USANA" or the "Company") (NYSE: USNA) and its board of directors concerning whether the board has ...
USANA Health Sciences [Part 3]: 'All Systems Go' On Valuation
ValueWalk - Jan 13, 2014
Continued from part two: Without even looking at USANA Health Sciences, Inc. (NYSE:USNA)'s valuation, the company has many attractive qualities.
USANA Health Sciences, Inc. : Usana Awarded with Nearly 100 Accolades In 2013 - 4-traders (press release)
Insider Trading at USANA Health Sciences Inc (USNA): Director Sells $500682 ...
Tech Insider - Sep 11, 2014
Myron W. Wentz, Director at USANA Health Sciences Inc (NYSE:USNA), sold last September 10th through an open market transaction 7,000 shares of Common Stock.
USANA Health Sciences Insider Unloads $2268370 in Stock (USNA)
WKRB News - Nov 6, 2014
USANA Health Sciences logo USANA Health Sciences (NASDAQ:USNA) Insider Dave Wentz unloaded 19,780 shares of the company's stock on the open market in a transaction that occurred on Monday, November 3rd.